Gemelli Biotech

Gemelli Biotech is a biotechnology company based in Raleigh, North Carolina. The company employs 26 individuals and generates revenue exceeding $10,000 annually. Gemelli Biotech specializes in developing non-invasive precision diagnostics centered around microbiome-related biological discoveries. Their focus is on providing clinicians with scientifically validated biomarkers to definitively detect and treat gastrointestinal (GI) diseases. These diseases include Small Intestinal Bacterial Overgrowth (SIBO), Irritable Bowel Movement (IMO), excess hydrogen sulfide, and post-infectious Irritable Bowel Syndrome (IBS). The company's approach sets them apart by utilizing cutting-edge biological research on the microbiome to offer precise diagnostic tools. This allows clinicians to make informed treatment decisions tailored to the individual patient's needs. Interested parties can learn more about Gemelli Biotech and their innovative diagnostic solutions by visiting their website at gemellibiotech.com.